PATENT CLAIM ANALYSIS

Application Number: 16062245
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "204100"]

Abstract:
Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.

Claim (Index 14):
The process of any one of  claims 3  to  13 , wherein the virus is propagated in a cell line selected from the group consisting of an EB66 cell line, a Vero cell line, a Vero-\u03b1His cell line, a HeLa cell line, a HeLa-S3 cell line, a 293 cell line, a PC12 cell line, a CHO cell line, a 3T3 cell line, a PerC6 cell line, a MDSK cell line, a chicken embryonic fibroblast cell line, a duck cell line, and a diploid avian cell line.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 94.0
- Lexical Diversity: 1.31034
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15781959', '16063007', '15212804', '15674585', '15674591']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7969654471061365
- 35 USC 102 Novelty (BERT): 0.6532753861207579
- Combined Prediction Score: 0.7825964410075986
- Mean Citation Score: 441.864336
- Max Citation Score: 668.9586
- Similarity Product: 597.2801124282362

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test